These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 10952317)

  • 21. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
    Gill HS; Char DH
    Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better prognostic determination and feature characterization of cutaneous melanoma through integrative genomic analysis.
    Li X; Cai Y
    Aging (Albany NY); 2019 Jul; 11(14):5081-5107. PubMed ID: 31322504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emperor's New Clothes: A Critique of the Current WHO Classification of Malignant Melanoma.
    Weyers W
    Am J Dermatopathol; 2020 Dec; 42(12):989-1002. PubMed ID: 32852290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G; Potter L; Daforno P; Pringle JH
    Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.
    van Dinten LC; Pul N; van Nieuwpoort AF; Out CJ; Jager MJ; van den Elsen PJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):24-30. PubMed ID: 15623750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular classification of uveal melanocytic lesions: an important discovery in context.
    Folberg R
    J Mol Diagn; 2010 Jul; 12(4):391-3. PubMed ID: 20522635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic classification of melanoma cells by phenotype-specific gene expression mapping.
    Widmer DS; Cheng PF; Eichhoff OM; Belloni BC; Zipser MC; Schlegel NC; Javelaud D; Mauviel A; Dummer R; Hoek KS
    Pigment Cell Melanoma Res; 2012 May; 25(3):343-53. PubMed ID: 22336146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.
    Kunz M; Koczan D; Ibrahim SM; Gillitzer R; Gross G; Thiesen HJ
    Acta Derm Venereol; 2002; 82(3):163-9. PubMed ID: 12353704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
    García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
    de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
    Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging insights into the molecular pathogenesis of uveal melanoma.
    Landreville S; Agapova OA; Harbour JW
    Future Oncol; 2008 Oct; 4(5):629-36. PubMed ID: 18922120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
    Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
    Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.
    Zhang G; Cheng Y; Chen G; Tang Y; Ardekani G; Rotte A; Martinka M; McElwee K; Xu X; Wang Q; Zhou Y
    Oncotarget; 2015 Sep; 6(26):23026-35. PubMed ID: 26246476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
    Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
    Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.